NSD2 and cancer: Similarly, the gain-of-function NSD2 E1099K with elevated H3K36me2 levels activates gene expression program associated with oncogenic KRAS signaling, thus promoting malignant tumor progression in lung adenocarcinoma (LUAD) [118].